Improving medication management for older adults with Alzheimer's disease and related dementias
eAlign: A Patient Portal-based Intervention to Align Medications with What Matters Most
This study is all about helping older adults with Alzheimer's and similar conditions manage their medications better by involving their caregivers, giving them helpful resources, and teaching them about non-drug options to improve behavior, so everyone can work together to make medication choices that fit the patient's needs and goals.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10908740 on NIH RePORTER |
What this research studies
This research focuses on helping older adults with Alzheimer's disease and related dementias (ADRD) manage their medications more effectively. It aims to engage care partners through a patient portal, providing them with educational resources to support the deprescribing of potentially harmful medications. The intervention includes training for care partners on non-drug treatments for behavioral symptoms and aims to reduce the overall medication burden on patients. By refining communication between patients, care partners, and healthcare providers, the project seeks to align medication decisions with the patients' personal goals.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults diagnosed with Alzheimer's disease or related dementias who are currently taking multiple medications.
Not a fit: Patients who are not diagnosed with Alzheimer's disease or related dementias or those who are not on multiple medications may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to safer medication practices and improved quality of life for patients with Alzheimer's disease and related dementias.
How similar studies have performed: Previous research has shown that interventions aimed at deprescribing can improve outcomes for patients with dementia, indicating a promising approach.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Green, Ariel — Johns Hopkins University
- Study coordinator: Green, Ariel
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.